Axio Biosolutions launches India’s first bleeding control awareness campaign

Partners with top hospitals for week-long training on bleeding control

Did you know that 20 per cent of global deaths due to road accidents occur in India? A vehicular accident is reported every two minutes on Indian roads, and a death every eight minutes. The disheartening fact is that most of these deaths could have been prevented. Unfortunately, there is a general lack of awareness in India about controlling life-threatening bleeding - something that could save millions of lives every year.

To address this grave concern, Axio Biosolutions, the first company from India to get USFDA approval for a wound dressing, is declaring ‘Stop the Bleed Day’ on 31st March 2018. The Bengaluru-based med-tech company aims to spread awareness and provide training on bleeding control on the lines of ‘Stop the Bleed Day’ organised in the US every year on the last day of March.

As part of this initiative, Axio Biosolutions is partnering with major hospitals across India, including AIIMS in Delhi, Zydus Hospital in Ahmedabad, Apollo Gleneagles Hospitals in Kolkata, Kamineni Hospital in Hyderabad, and Manipal Hospital and Columbia Asia in Bengaluru. The plan is to provide an extensive, week-long training (24th–30th March 2018) to doctors, nurses and paramedic staff in using Axiostat, the company’s flagship product which is being used by Indian armed forces to stop bleeding in battlefields.

Commenting on the campaign, Leo Mavely, CEO, Axio Biosolutions, said, “The most common cause of preventable death following injury is uncontrolled bleeding. The longer someone bleeds, the higher the chance that they will succumb to their injuries. Our aim is not only to train hospital and paramedic staff on how to stop uncontrollable bleeding, but also the by-standers because accidents can happen at any time. ‘Stop the Bleed Day’ is our earnest attempt to spread awareness and save maximum lives. For, every life is precious!”

Axiostat – advanced haemostatic dressing will be used free of cost to treat patients with bleeding in trauma cases on 30th & 31st March, 2018 in the partner hospitals. Even the waiting rooms of the trauma/emergency departments will be equipped to teach the public ways to control bleeding with gauze and tourniquets in case of an accident.

Axiostat is the de-facto first-aid dressing of Indian armed forces as well as of multiple hospitals dealing with trauma and road accident victims. It is known to stop profuse bleeding within just two minutes of application. As the first Indian company to launch an indigenously developed emergency haemostat for trauma care, Axio Biosolutions has been steadily disrupting the wound care market. They have their corporate office in Bengaluru and Axiostat is currently manufactured at their GMP, ISO 13485-certified manufacturing facility in Gujarat.